Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (191-200 of 466) with videos related to

Pageof 47
Sort By:
Leukemia|March 18, 2021
EOMES is essential for antitumor activity of CD8<sup>+</sup> T cells in chronic lymphocytic leukemiaLaura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, et al.
Cancers|January 21, 2022
Longitudinal CT Imaging to Explore the Predictive Power of 3D Radiomic Tumour Heterogeneity in Precise Imaging of Mantle Cell Lymphoma (MCL)Catharina Silvia Lisson, Christoph Gerhard Lisson, Sherin Achilles, et al.
Blood|July 29, 2011
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignanciesKarl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Future Oncology (London, England)|February 22, 2018
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemiaPaula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
European Journal of Immunology|April 16, 2010
CD5+ B cells from individuals with systemic lupus erythematosus express granzyme BMagdalena Hagn, Verena Ebel, Kai Sontheimer, et al.
Haematologica|May 11, 2019
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemiaSalih Demir, Elena Boldrin, Qian Sun, et al.
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
Pageof 47

Showing results (191-200 of 466) with videos related to

Sort By:
Pageof 47
Leukemia|March 18, 2021
EOMES is essential for antitumor activity of CD8<sup>+</sup> T cells in chronic lymphocytic leukemiaLaura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, et al.
Cancers|January 21, 2022
Longitudinal CT Imaging to Explore the Predictive Power of 3D Radiomic Tumour Heterogeneity in Precise Imaging of Mantle Cell Lymphoma (MCL)Catharina Silvia Lisson, Christoph Gerhard Lisson, Sherin Achilles, et al.
Blood|July 29, 2011
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignanciesKarl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, et al.
Haematologica|August 18, 2010
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical riskDirk Winkler, Christof Schneider, Manuela Zucknick, et al.
Future Oncology (London, England)|February 22, 2018
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemiaPaula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
European Journal of Immunology|April 16, 2010
CD5+ B cells from individuals with systemic lupus erythematosus express granzyme BMagdalena Hagn, Verena Ebel, Kai Sontheimer, et al.
Haematologica|May 11, 2019
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemiaSalih Demir, Elena Boldrin, Qian Sun, et al.
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
Pageof 47